Recurrent Pregnancy Loss in Delhi: Understanding Causes, Diagnosis & Your Path to a Successful Pregnancy

Recurrent Pregnancy Loss is not simply bad luck repeated — it is a medical condition with identifiable, often treatable underlying causes. The Royal College of Obstetricians and Gynaecologists (RCOG) and most Indian reproductive medicine societies define RPL as two or more clinical pregnancy losses, though many specialists recommend beginning investigation after the second loss, especially in women over 35.

Delhi's unique demographic profile makes it a hotspot for RPL consultations. The city has one of India's highest proportions of women postponing first pregnancies into their late 30s for career reasons — a trend particularly visible in South Delhi's professional corridors and in newer residential hubs like Dwarka Sector 12 and Rohini. Alongside age-related factors, Delhi's air quality index frequently breaches hazardous thresholds; emerging research links chronic particulate-matter exposure to endometrial inflammation and implantation failure, both of which can contribute to early pregnancy loss.

Additionally, lifestyle factors prevalent in urban Delhi — high psychological stress, disrupted sleep cycles, insulin resistance linked to a carbohydrate-heavy diet, and thyroid dysfunction — each independently elevate RPL risk. Understanding this local context is the first step toward a workup that actually reflects a Delhi patient's life.

The causes of RPL are best understood across several biological domains, and a thorough evaluation should address all of them systematically.

**Genetic and Chromosomal Factors:** Approximately 50–60% of sporadic first-trimester losses are caused by chromosomal abnormalities in the embryo — most commonly trisomies. In RPL specifically, parental balanced chromosomal translocations are found in 3–5% of couples; these structural rearrangements cause recurrent abnormal embryo formation without producing visible abnormalities in the parents.

**Uterine Structural Abnormalities:** Conditions such as a septate uterus, submucosal fibroids, intrauterine adhesions (Asherman's syndrome), and a bicornuate uterus physically disrupt implantation or fetal blood supply. Uterine anomalies are found in 10–15% of RPL patients in Indian reproductive units.

**Thrombophilic Disorders:** Antiphospholipid Antibody Syndrome (APS) is the most important acquired thrombophilia in RPL, identified in 5–20% of cases. APS causes micro-clots in placental vessels, cutting off fetal nutrition. Inherited thrombophilias like Factor V Leiden mutations are also screened.

**Endocrine Dysfunction:** Poorly controlled hypothyroidism, hyperprolactinaemia, PCOS-related insulin resistance, and undiagnosed diabetes all significantly raise miscarriage risk. Thyroid dysfunction is particularly prevalent among Delhi women, making TSH optimisation a cornerstone of RPL management.

**Immunological Factors:** Natural killer (NK) cell dysregulation and alloimmune mechanisms are areas of active research. While not yet universally agreed upon, many Indian RPL specialists include immunological panels in their workup.

Many couples in Delhi hesitate to seek a formal RPL evaluation, believing that doctors will advise them to 'try again naturally.' While optimism is warranted in some cases, waiting beyond two losses — particularly in women over 35 — can cost precious reproductive time.

You should seek a dedicated RPL consultation if you have experienced two or more pregnancy losses at any gestational age, one loss after 10 weeks (as late losses are more likely to have an identifiable cause), or one loss in the context of a known risk factor such as PCOS, thyroid disease, a structural uterine anomaly, or a clotting disorder.

Physical symptoms that accompany RPL — such as heavy, irregular cycles, mid-cycle spotting, recurrent pelvic pain, or difficulty conceiving between losses — should also prompt early evaluation rather than watchful waiting.

For couples in areas like Rohini or Dwarka where specialist access can involve long travel and waiting times, HomeIVF's model of home-based diagnostics and telemedicine consultations removes the logistical barriers that too often delay timely care. The HomeIVF Medical Board recommends that no couple should navigate a third loss without at least having had a baseline RPL panel completed.

A comprehensive RPL evaluation is not a single test — it is a coordinated panel that investigates all plausible causes simultaneously, saving both time and emotional energy.

**Genetic Testing:** Karyotyping of both partners (peripheral blood) to detect balanced translocations; products of conception (POC) analysis after each loss to determine if a chromosomal abnormality caused that specific miscarriage.

**Uterine Assessment:** 3D transvaginal ultrasound is the first-line imaging modality for uterine anatomy. Saline infusion sonography (SIS) or hysteroscopy may be required for submucosal fibroids or intrauterine adhesions. Many South Delhi diagnostic centres offer 3D pelvic ultrasound, and HomeIVF coordinates sample logistics so patients in Dwarka or Rohini do not need to visit multiple facilities.

**Hormonal Panel:** TSH, free T4, prolactin, fasting insulin, HbA1c, AMH (to assess ovarian reserve), and Day 2–3 FSH/LH/estradiol. For PCOS-related RPL, an androgen panel is added.

**Thrombophilia Screen:** Lupus anticoagulant, anticardiolipin antibodies (IgG and IgM), anti-beta-2 glycoprotein antibodies repeated 12 weeks apart to confirm APS; Factor V Leiden and MTHFR mutations.

**Immunological Tests:** NK cell assay, antinuclear antibodies (ANA), and anti-thyroid peroxidase (TPO) antibodies are included in extended panels at HomeIVF.

All test coordination, home blood draws, and report interpretation under the HomeIVF Medical Board can be arranged for Delhi patients without stepping out of their homes.

Treatment for RPL is highly cause-specific, and therein lies the importance of the diagnostic workup — there is no universal protocol.

**For Chromosomal RPL:** Preimplantation Genetic Testing for Aneuploidies (PGT-A) during an IVF cycle allows embryologists to screen embryos for chromosomal abnormalities before transfer, dramatically increasing the chance of a viable implantation. For couples with balanced translocations, PGT-SR (structural rearrangements) testing is specifically indicated.

**For Uterine Anomalies:** Hysteroscopic resection of a uterine septum, polypectomy, myomectomy for submucosal fibroids, or adhesiolysis for Asherman's syndrome are day-care surgical procedures that significantly improve subsequent pregnancy outcomes.

**For APS:** Low-dose aspirin combined with low-molecular-weight heparin (LMWH) injections from a positive pregnancy test through 34–36 weeks of gestation reduces pregnancy loss rates by over 50% in confirmed APS patients — one of the most evidence-backed interventions in reproductive medicine.

**For Endocrine Causes:** Meticulous thyroid optimisation (TSH kept below 2.5 mIU/L in pregnancy), metformin for insulin-resistant PCOS, and prolactin normalisation with cabergoline all contribute meaningfully to live birth rates.

**For Unexplained RPL:** Progesterone supplementation (vaginal micronised progesterone 400 mg twice daily from positive hCG until 12 weeks) showed a statistically significant benefit in the UK-based PRISM trial, and is now standard practice. Lifestyle modification counselling — including stress reduction, anti-inflammatory diet, and sleep hygiene — is part of every HomeIVF RPL care plan.

HomeIVF was built on a single principle: that geography and logistics should never compromise the quality of fertility care. For RPL patients in Delhi — who are already emotionally exhausted from repeated losses — having to commute across the city, sit in crowded waiting rooms, and coordinate between multiple specialists adds unnecessary burden.

HomeIVF delivers senior-specialist care at home. The HomeIVF Medical Board oversees a structured RPL programme that includes a 60-minute video consultation with a senior reproductive medicine specialist, a coordinated home-sample-collection service for blood and genetic tests available across South Delhi, Dwarka, Rohini, and most of Delhi NCR, tele-reporting and detailed written management plans, and ongoing pregnancy monitoring with home-based progesterone and hCG draws.

For couples who require IVF with PGT-A, HomeIVF's IVF packages start from ₹1.5 lakh, making advanced chromosomal screening accessible without the premium typically associated with Delhi's larger hospital networks. The programme is designed to feel like having a dedicated reproductive specialist as a family member — available, responsive, and deeply invested in your outcome.

Every care plan is personalised; no two RPL journeys are identical, and HomeIVF's protocol reflects that.

One of the most anxiety-provoking aspects of RPL is uncertainty about timelines. A realistic, phased timeline helps couples plan emotionally and practically.

**Phase 1 — Diagnostic Workup (Weeks 1–4):** Blood panels, genetic karyotyping, and uterine imaging are typically completed within 2–4 weeks in Delhi's well-equipped diagnostic ecosystem. HomeIVF coordinates all logistics, with most results consolidated into a single comprehensive report.

**Phase 2 — Specialist Consultation and Plan Formulation (Week 4–5):** The HomeIVF Medical Board reviews all results and drafts a cause-specific management plan, including whether natural conception with medical support, surgical correction, or IVF with PGT-A is the recommended pathway.

**Phase 3 — Intervention (Variable):** Hysteroscopic surgery, when needed, is typically a day-care procedure with a 6–8 week recovery before attempting conception. Medical treatment (aspirin + heparin, thyroid correction, progesterone protocol) can begin in the very next cycle. An IVF cycle with PGT-A spans approximately 3–4 weeks of stimulation, retrieval, and genetic testing before a frozen embryo transfer.

**Phase 4 — Monitored Conception (Ongoing):** Once pregnant, RPL patients require intensified early pregnancy monitoring — weekly hCG, progesterone levels, and early viability scans at 6–8 weeks. HomeIVF's home-monitoring service means Delhi patients in Rohini or Dwarka do not need to rush to a clinic for every anxiety-driven blood draw.

Delhi's healthcare infrastructure is world-class at the top tier, yet deeply unequal in access. Long appointment waits at major hospital fertility units, fragmented care between gynaecologist and reproductive medicine specialist, high out-of-pocket costs at premium centres, and the sheer physical exhaustion of navigating Delhi traffic — all act as real barriers to timely RPL evaluation.

Language and cultural sensitivity matter too. Discussing repeated pregnancy loss requires a safe, unhurried space — something that a 10-minute hospital OPD slot rarely provides. Many couples from areas like Rohini or outer Dwarka also express discomfort discussing infertility and loss in shared waiting rooms.

HomeIVF systematically removes these barriers. Consultations are conducted in the patient's preferred language (Hindi or English) via secure video call, at a time chosen by the couple. Home sample collection eliminates travel. A single point-of-contact care coordinator manages every step from first consultation to early pregnancy monitoring, so patients are never left wondering who to call after an abnormal result.

The HomeIVF Medical Board also ensures that every RPL workup in Delhi follows updated international protocols — not outdated or incomplete panels — so that no treatable cause is missed. For couples who have already spent years and enormous emotional capital on repeated losses, that thoroughness is not a luxury; it is the minimum they deserve.